|
| Press Releases |
|
 |
|
| Wednesday, September 8, 2021 |
|
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药，一家专注于肿瘤治疗领域的创新型全球生物制药公司，今日宣布其口服泛PI3K抑制剂buparlisib（AN2025）、口服EP4拮抗剂（AN0025）与PD-L1抑制剂atezolizumab（阿替利珠单抗）三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。
more info >> |
|
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
| 阿諾醫藥，一家專注於腫瘤治療領域的創新型全球生物製藥公司，今日宣佈其口服泛PI3K抑制劑buparlisib（AN2025）、口服EP4拮抗劑（AN0025）與PD-L1抑制劑atezolizumab（阿替利珠單抗）三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
| Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
| Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 22:00: JST
|
|
|
Revolutionary Blockchain-based Dancing Platform, DANSA to Be Launched Soon
Aug 10, 2022 21:00 HKT/SGT
|
|
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT/SGT
|
|
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT/SGT
|
|
|
TTI Delivers Strong 2022 First Half Results
Aug 10, 2022 20:34: JST
|
|
|
创科实业于二零二二年上半年创下骄人业绩
Aug 10, 2022 19:27 HKT/SGT
|
|
|
創科實業於二零二二年上半年創下驕人業績
Aug 10, 2022 19:26 HKT/SGT
|
|
|
TTI Delivers Strong 2022 First Half Results
Aug 10, 2022 19:25 HKT/SGT
|
|
|
TOYOTA、9月 生産計画について発表
Aug 10, 2022 17:00: JST
|
|
|
Honda、2022年度第1四半期決算および通期業績見通しを発表
Aug 10, 2022 15:30: JST
|
|
|
三菱自動車、MIRAI-LABO、電動車の使用済みバッテリーを用いた自律型街路灯の開発検討を開始
Aug 10, 2022 15:00: JST
|
|
|
《滨海宁波·扬帆世界》邓蓓佳独家专访周莉莉：香港当好超级联系人 联合国秘书长特使建言献策
Aug 10, 2022 13:59 HKT/SGT
|
|
|
《濱海寧波·揚帆世界》鄧蓓佳獨家專訪周莉莉：香港當好超級聯繫人 聯合國秘書長特使建言獻策
Aug 10, 2022 13:58 HKT/SGT
|
|
|
Bintai Kinden to Market O&G Equipment in Indonesia
Aug 10, 2022 13:00 HKT/SGT
|
|
|
Society Pass backed Thoughtful Media Group Announces New CEO and Vision to be the Leader in Digital and Social Commerce in SEA
Aug 10, 2022 12:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
